Origin and levels of circulating microparticles in normal pregnancy: A longitudinal observation in healthy women

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 75, Issue 6, 2015, Pages 487-495

  Radu, Claudia M ^a   Campello, Elena ^a   Spiezia, Luca ^a   Dhima, Sonila ^a   Visentin, Silvia ^a   Gavasso, Sabrina ^a   Woodhams, Barry ^b   Cosmi, Erich ^a   Simioni, Paolo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b HaemaCon Ltd   (United Kingdom)

Author keywords

Coagulation and atherothrombosis; Flow cytometry; Gynecology; Hematology; Laboratory standardization

Indexed keywords

MONOCLONAL ANTIBODY; PROCOAGULANT; THROMBOPLASTIN;

ADULT; ARTICLE; BLOOD ANALYSIS EQUIPMENT; BLOOD CLOTTING TEST; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; FLOW CYTOMETER; FLOW CYTOMETRY; HUMAN; HUMAN EXPERIMENT; INTERNATIONAL NORMALIZED RATIO; MEMBRANE MICROPARTICLE; NORMAL HUMAN; OBSERVATIONAL STUDY; PARTIAL THROMBOPLASTIN TIME; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; THROMBOCYTE COUNT; BLOOD; BLOOD CLOTTING; CASE CONTROL STUDY; CYTOLOGY; LEUKOCYTE; LONGITUDINAL STUDY; METABOLISM; PHYSIOLOGY; PREGNANCY; REFERENCE VALUE;

ADULT; BLOOD COAGULATION; CASE-CONTROL STUDIES; CELL-DERIVED MICROPARTICLES; FEMALE; HUMANS; LEUKOCYTES; LONGITUDINAL STUDIES; PREGNANCY; PREGNANCY TRIMESTERS; REFERENCE VALUES; THROMBOPLASTIN;

EID: 84937942547     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2015.1052551     Document Type: Article

References (39)

1. Alijotas-Reig J, Palacio-Garcia C, Llurba E, Vilardell-Tarres M. Cell-derived microparticles and vascular pregnancy complications: a systematic and comprehensive review. Fertil Steril 2013; 99: 441-9.
2. Dusse LM, Rios DR, Pinheiro MB, Cooper A J, Lwaleed BA. Pre-eclampsia: relationship between coagulation, fibrinolysis and infl ammation. Clin Chim Acta 2011; 412: 17-21.
3. Barco S, Nijkeuter M, Middeldorp S. P regnancy and venous thromboembolism. Semin Thromb Hemost 2013; 39: 549-58.
4. A ustgulen R, Lien E, Vince G, Redman C. I ncreased maternal plasma levels of soluble adhesion molecules (ICAM-1, V-CAM-1, E-selectin) in preeclampsia. Eur J Obstet Gynecol Reprod Biol 1997; 71: 53-8.
5. Clausen T, Djurovic S, Brosstad F, Berg K, Henriksen T. Altered circulating levels of adhesion molecules at 18 week ' s gestation among women with eventual preeclampsia: indicators of disturbed placentation in absence of evidence of endothelial dysfunction Am J Obstet Gynecol 2000; 182: 321-5.
6. Redman CW, Sargent IL. C irculating microparticles in normal pregnancy and pre-eclampsia. Placenta 2008; 29: S73-7.
7. Barteneva NS, Fasler-Kan E, Bernimoulin M, Stern JN, Ponomarev ED, Duckett L, Vorobjev IA. Circulating microparticles: square the circle. BMC Cell Biol 2013; 14: 23.
8. Wu ZH, Ji CL, Li H, Qiu GX, Gao CJ, Weng XS. M embrane microparticles and diseases. Eur Rev Med Pharmacol Sci 2013; 17: 2420-7.
9. Burger D, Schock S, Thompson CS, Montezano A C, Hakim AM, Touyz RM. Microparticles: biomarkers and beyond. Clin Sci (Lond) 2013; 124: 423-41.
10. Rautou PE, Vion AC, Amabile N, Chironi G, Simon A, Tedgui A, Boulanger CM. Microparticles, vascular function, and atherothrombosis. Circ Res 2011; 109: 593-606.
11. Tissot J D, Rubin O, Canellini G. A nalysis and clinical relevance of microparticles from red blood cells. Curr Opin Hematol 2010; 17: 571-7.
12. Antoniak S, Boltzen U, Eisenreich A, Stellbaum C, Poller W, Schultheiss HP, Rauch U. Regulation of cardiomyocyte fulllength tissue factor expression and microparticle release under infl ammatory conditions in vitro. J Thromb Haemostasis 2009; 7: 871-8.
13. Campello E, Spiezia L, Radu CM, Bulato C, Castelli M, Gavasso S, Simioni P. Endothelial, platelet and tissue factorbearing microparticles in cancer patients with and without venous thrombembolism. Thromb Res 2011; 127: 473-7.
14. Pirro M, Schillaci G, Bagaglia F, Menecali C, Paltriccia R, Mannarino MR, Capanni M, Velardi A, Mannarino E. Microparticles derived from endothelial progenitor cells in patients at different cardiovascular risk. Atherosclerosis 2008; 197; 757-67.
15. Lacroix R, Dubois C, Leroyer A S, Sabatier F, Dignat-George F. Revisited role of microparticles in arterial and venous thrombosis. J Thromb Haemost 2013; 11: 24-35.
16. Markiewicz M, Richard E, Marks N, Ludwicka-Bradley A. Impact of endothelial microparticles on coagulation, infl ammation, and angiogenesis in age-related vascular diseases. J Aging Res 2013; doi: 10.1155/2013/734509.
17. Mause SF, Weber C. M icroparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 2010; 107: 1047-57.
18. Marques FK, Campos FM, Sousa LP, Teixeira-Carvalho A, Dusse LM, Gomes KB. Association of microparticles and preeclampsia. Mol Biol Rep 2013; 40: 4553-9.
19. Aharon A, Brenner B. M icroparticles and pregnancy complications. Thromb Res 2011; 127: S67-71.
20. Lippi G, Franchini M, Montagnana M, Salvagno G L, Poli G, Guidi GC. Quality and reliability of routine coagulation testing: can we trust that sample Blood Coagul Fibrinolysis 2006; 17: 513-9.
21. van Beers E J, Schaap M C, Berckmans R J, Nieuwland R, Sturk A, van Doormaal FF, Meijers JC, Biemond BJ; CURAMA study group. Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica 2009; 94: 1513-9.
22. Simioni P, Tormene D, Spiezia L, Tognin G, Rossetto V, Radu C, Prandoni P. Inherited thrombophilia and venous thromboembolism. Semin Thromb Hemost 2006; 32: 700-8.
23. Rossetto V, Spiezia L, Franz F, Salmaso L, Pozza LV, Gavasso S, Simioni P. The role of antiphospholipid antibodies toward the protein C/protein S system in venous thromboembolic disease. Am J Hematol 2009; 84: 594-6.
24. Campello E, Spiezia L, Radu CM, Bon M, Gavasso S, Zerbinati P, Woodhams B, Tormene D, Prandoni P, Simioni P. Circulating microparticles in carriers of factor V Leiden with and without a history of venous thrombosis. Thromb Haemost 2012; 108: 633-9.
25. Robert S, Poncelet P, Lacroix R, Arnaud L, Giraudo L, Hauchard A, Sampol J, Dignat-George F. Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine fl ow cytometer: a first step towards multicentre studies J Thromb Haemost 2009; 7: 190-7.
26. van Dreden P, Rousseau A, Fontaine S, Woodhams B, Exner T. Clinical evaluation of a new functional test for detection of plasma procoagulant phospholipids. Blood Coag Fibrinolysis 2009; 20: 494-502.
27. Campello E, Spiezia L, Radu C M, Gavasso S, Woodhams B, Simioni P. Evaluation of a procoagulant phosholipid functional assay as a routine test for measuring circulating microparticle activity. Blood Coagul Fibrinolysis 2014; 25: 534-7
28. Bretelle F, Sabatier F, Desprez D, Camin L, Grunebaum L, Combes V, D' Ercole C, Dignat-George F. Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intra uterine growth restriction. Thromb Haemost 2003; 89: 486-92
29. Alijotas-Reig, Palacio-Garcia C, Farran-Codina I, Zarzoso C, Cabero-Roura L, Vilardell-Tarres M. Circulating cellderived microparticles in women with pregnancy loss. Am J Reprod Immunol 2001; 66: 199-208.
30. Lok CA, Van Der Post JA, Sargent IL, Hau CM, Sturk A, Boer K, Nieuwland R. Changes in microparticle numbers and cellular origin during pregnancy and preeclampsia. Hyperten Pregnancy 2008; 27: 344-60.
31. Chen M, Geng JG. P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in infl ammation, thrombosis, and cancer growth and metastasis. Arch Immunol Ther Exp 2006; 54: 75-84.
32. Khew-Goodall Y, Butcher CM, Litwin MS, Newlands S, Korpelainen EI, Noack LM, Berndt MC, Lopez AF, Gamble JR, Vadas MA. Chronic expression of P-selectin on endothelial cells stimulated by the T-cell cytokine, interleukin-3. Blood 1996; 87: 1432-8.
33. Morel O, Luca F, Grunebaum L. S hort-term very lowcalorie diet in obese females improves the haemostatic balance through the reduction of leptin levels, PAI-1 concentrations and a diminished release of platelet and leukocyte-derived microparticles. Int J Obes 2011; 35: 1479-86.
34. Furie B, Furie B C. M echanisms of thrombus formation. N Engl J Med 2008; 359: 938-49.
35. Lacroix R, Judicone C, Poncelet P, Robert S, Arnaud L, Sampol J, Dignat-George F. Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol. J Thromb Haemost 2012; 10: 437-46.
36. Yuana Y, Bertina RM, Osanto S. P re-analytical and analytical issues in the analysis of blood microparticles. Thromb Haemost 2011; 105: 396-408.
37. Lacroix R, Judicone C, Mooberry M, Boucekine M, Key NS, Dignat-George F; The ISTH SSC Workshop. Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost 2013; 11: 1190-3.
38. Robert S, Lacroix R, Poncelet P, Harhouri K, Bouriche T, Judicone C, Wischhusen J, Arnaud L, Dignat-George F. High-sensitivity fl ow cytometry provides access to standardized measurement of small-size microparticles-brief report. Arterioscler Thromb Vasc Biol 2012; 32: 1054-8.
39. Lacroix R, Dubois C, Leroyer AS, Sabatier F, Dignat-George F. Revisited role of microparticles in arterial and venous thrombosis. J Thromb Haemost 2013; 11: 24-35.